| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Air pollution and asthma incidence: doubt no more?
|
Georas, Steve N
|
|
2015
|
3 |
12 |
p. 902-903
2 p.
|
article
|
| 2 |
ARDS in 2015: new clinical directions, new biological insights
|
Calfee, Carolyn S
|
|
2015
|
3 |
12 |
p. 912-913
2 p.
|
article
|
| 3 |
Asthma: a focus on four key areas in 2015
|
Weiss, Scott T
|
|
2015
|
3 |
12 |
p. 913-915
3 p.
|
article
|
| 4 |
AstraZeneca halts two lung cancer drug trials
|
Gourd, Katherine
|
|
2015
|
3 |
12 |
p. 926-
1 p.
|
article
|
| 5 |
Bronchiectasis: working together for better evidence
|
Chalmers, James D
|
|
2015
|
3 |
12 |
p. 915-917
3 p.
|
article
|
| 6 |
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis
|
Kendall, Emily A
|
|
2015
|
3 |
12 |
p. 963-972
10 p.
|
article
|
| 7 |
Cardiovascular and neuropsychiatric risks of varenicline: too good to be true?
|
Odeyale, Foluke
|
|
2015
|
3 |
12 |
p. e38-
1 p.
|
article
|
| 8 |
Cardiovascular and neuropsychiatric risks of varenicline: too good to be true?
|
Nielen, Johannes T H
|
|
2015
|
3 |
12 |
p. e38-e39
nvt p.
|
article
|
| 9 |
Cardiovascular and neuropsychiatric risks of varenicline: too good to be true?
|
Davies, Neil M
|
|
2015
|
3 |
12 |
p. e39-e40
nvt p.
|
article
|
| 10 |
Cardiovascular and neuropsychiatric risks of varenicline: too good to be true? – Authors' reply
|
Kotz, Daniel
|
|
2015
|
3 |
12 |
p. e40-e42
nvt p.
|
article
|
| 11 |
Changing minds about tuberculosis
|
The Lancet Respiratory Medicine,
|
|
2015
|
3 |
12 |
p. 901-
1 p.
|
article
|
| 12 |
CHEST Annual meeting 2015
|
Burki, Talha Khan
|
|
2015
|
3 |
12 |
p. 925-
1 p.
|
article
|
| 13 |
Childhood asthma prediction models: a systematic review
|
Smit, Henriette A
|
|
2015
|
3 |
12 |
p. 973-984
12 p.
|
article
|
| 14 |
Corrections
|
|
|
2015
|
3 |
12 |
p. e44-
1 p.
|
article
|
| 15 |
Corrections
|
|
|
2015
|
3 |
12 |
p. e44-
1 p.
|
article
|
| 16 |
Corrections
|
|
|
2015
|
3 |
12 |
p. e44-
1 p.
|
article
|
| 17 |
Exposure to air pollution and development of asthma and rhinoconjunctivitis throughout childhood and adolescence: a population-based birth cohort study
|
Gehring, Ulrike
|
|
2015
|
3 |
12 |
p. 933-942
10 p.
|
article
|
| 18 |
First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine
|
Geldmacher, Christof
|
|
2015
|
3 |
12 |
p. 906-907
2 p.
|
article
|
| 19 |
Getting the story
|
Jones, Barbara
|
|
2015
|
3 |
12 |
p. 932-
1 p.
|
article
|
| 20 |
Hyperinflation in COPD exacerbations
|
van Geffen, Wouter H
|
|
2015
|
3 |
12 |
p. e43-e44
nvt p.
|
article
|
| 21 |
Idiopathic pulmonary fibrosis: continuing to make progress
|
Lee, Joyce S
|
|
2015
|
3 |
12 |
p. 921-923
3 p.
|
article
|
| 22 |
Immunotherapy: the third wave in lung cancer treatment
|
Heigener, David Felix
|
|
2015
|
3 |
12 |
p. 923-924
2 p.
|
article
|
| 23 |
Inhaled budesonide in bronchopulmonary dysplasia
|
Yaqub, Farhat
|
|
2015
|
3 |
12 |
p. 926-
1 p.
|
article
|
| 24 |
International donor conversion rates for lung transplantation need to be standardised
|
Riddell, Peter
|
|
2015
|
3 |
12 |
p. 909-911
3 p.
|
article
|
| 25 |
Jonas Salk
|
Akkermans, Rebecca
|
|
2015
|
3 |
12 |
p. 930-931
2 p.
|
article
|
| 26 |
Lessons for pulmonary critical care from treatment of Ebola virus disease in developed countries
|
Bhadelia, Nahid
|
|
2015
|
3 |
12 |
p. 919-921
3 p.
|
article
|
| 27 |
Lung health care—what does the future have in store?
|
Thorley, Jennifer
|
|
2015
|
3 |
12 |
p. 927-
1 p.
|
article
|
| 28 |
MDR tuberculosis control: time to change the dogma?
|
Van Rie, Annelies
|
|
2015
|
3 |
12 |
p. 907-909
3 p.
|
article
|
| 29 |
Nutritional support and refeeding syndrome in critical illness
|
van Zanten, Arthur Raymond Hubert
|
|
2015
|
3 |
12 |
p. 904-905
2 p.
|
article
|
| 30 |
Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial
|
Doig, Gordon S
|
|
2015
|
3 |
12 |
p. 943-952
10 p.
|
article
|
| 31 |
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
|
Spertini, François
|
|
2015
|
3 |
12 |
p. 953-962
10 p.
|
article
|
| 32 |
SUPPORT controversy's lessons for informed consent
|
Furlow, Bryant
|
|
2015
|
3 |
12 |
p. 928-929
2 p.
|
article
|
| 33 |
The complex challenge of chronic obstructive pulmonary disease
|
Duffy, Sean
|
|
2015
|
3 |
12 |
p. 917-919
3 p.
|
article
|
| 34 |
Use of FEV1 as a measure of lung health in the UK BiLEVE study
|
Warner, David O
|
|
2015
|
3 |
12 |
p. e42-
1 p.
|
article
|
| 35 |
Use of FEV1 as a measure of lung health in the UK BiLEVE study – Authors' reply
|
Wain, Louise V
|
|
2015
|
3 |
12 |
p. e42-e43
nvt p.
|
article
|
Journal description